Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 191,071	$ 201,606
Accounts receivable, net	66,170	56,393
Inventories, net	149,030	144,609
Income taxes receivable	2,175	1,559
Derivative financial instruments	40,598	38,298
Other current assets	24,455	17,464
Total current assets	473,499	459,929
Property, plant and equipment, net	386,277	398,599
Deferred income tax assets, net	35,106	52,213
Intangibles, net	27,637	33,242
Derivative financial instruments	39,670	40,471
Other noncurrent assets	43,323	46,117
Total assets	1,005,512	1,030,571
Current liabilities:
Accounts payable	139,856	124,907
Short-term debt	4,571	5,322
Accrued expenses	65,818	66,838
Income taxes payable	1,920	1,844
Total current liabilities	212,165	198,911
Long-term debt (less current portion)	605,046	610,632
Noncurrent income tax liabilities	5,795	8,129
Deferred income tax liabilities, net	1,403	1,903
Other noncurrent liabilities	48,296	47,821
Commitments and contingent liabilities (Note 17)
Mezzanine equity:
Preferred stock, $0.01 par value Authorized - 1,000,000 sharesIssued and outstanding - 150,000 shares outstanding at March 31, 2024 and December 31, 2023	255,032	248,222
European noncontrolling redeemable equity	682	893
Shareholders' deficit:
Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding - 28,600,152 and 28,091,440 shares at March 31, 2024 and December 31, 2023	115,924	115,340
Accumulated other comprehensive loss	(16,920)	(22,291)
Retained earnings	(221,911)	(178,989)
Total shareholders' deficit	(122,907)	(85,940)
Total liabilities, mezzanine equity and shareholders' deficit	$ 1,005,512	$ 1,030,571